Literature DB >> 19337216

Regulation of renal arteriolar tone by adenosine: novel role for type 2 receptors.

Tracy D Bell, William J Welch.   

Abstract

Tubuloglomerular feedback regulation of glomerular filtration rate (GFR) is mediated by adenosine, which acts on type 1 receptors in the afferent arteriole to increase resistance. However, new findings in isolated mouse tissue suggest that adenosine also dilates the efferent arteriole, which would reinforce the ability of adenosine to reduce GFR. This new information extends the concept that adenosine acts as a paracrine agent on both afferent and efferent arterioles.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19337216      PMCID: PMC5858198          DOI: 10.1038/ki.2009.18

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  8 in total

1.  Efferent arteriole tubuloglomerular feedback in the renal nephron.

Authors:  Y Ren; J L Garvin; O A Carretero
Journal:  Kidney Int       Date:  2001-01       Impact factor: 10.612

2.  Abolished tubuloglomerular feedback and increased plasma renin in adenosine A1 receptor-deficient mice.

Authors:  R Brown; A Ollerstam; B Johansson; O Skøtt; S Gebre-Medhin; B Fredholm; A E Persson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2001-11       Impact factor: 3.619

Review 3.  Mediators of tubuloglomerular feedback regulation of glomerular filtration: ATP and adenosine.

Authors:  H Castrop
Journal:  Acta Physiol (Oxf)       Date:  2007-01       Impact factor: 6.311

Review 4.  Role of interstitial ATP and adenosine in the regulation of renal hemodynamics and microvascular function.

Authors:  Akira Nishiyama; Matlubur Rahman; Edward W Inscho
Journal:  Hypertens Res       Date:  2004-11       Impact factor: 3.872

5.  Mediation of tubuloglomerular feedback by adenosine: evidence from mice lacking adenosine 1 receptors.

Authors:  D Sun; L C Samuelson; T Yang; Y Huang; A Paliege; T Saunders; J Briggs; J Schnermann
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-14       Impact factor: 11.205

6.  Interactions of adenosine A1 and A2a receptors on renal microvascular reactivity.

Authors:  A Nishiyama; E W Inscho; L G Navar
Journal:  Am J Physiol Renal Physiol       Date:  2001-03

7.  Adenosine A2 receptor activation attenuates afferent arteriolar autoregulation during adenosine receptor saturation in rats.

Authors:  Ming-Guo Feng; L Gabriel Navar
Journal:  Hypertension       Date:  2007-07-30       Impact factor: 10.190

8.  Activation of A(2) adenosine receptors dilates cortical efferent arterioles in mouse.

Authors:  Rozh H Al-Mashhadi; Ole Skøtt; Paul M Vanhoutte; Pernille B Hansen
Journal:  Kidney Int       Date:  2009-01-21       Impact factor: 10.612

  8 in total
  6 in total

1.  Afferent arteriolar vasodilator effect of adenosine predominantly involves adenosine A2B receptor activation.

Authors:  Ming-Guo Feng; L Gabriel Navar
Journal:  Am J Physiol Renal Physiol       Date:  2010-05-12

2.  Sensitivity of USPIO-enhanced R2 imaging to dynamic blood volume changes in the rat kidney.

Authors:  Pippa Storey; Lin Ji; Lu-Ping Li; Pottumarthi V Prasad
Journal:  J Magn Reson Imaging       Date:  2011-05       Impact factor: 4.813

3.  Urine metabolomics reveals biomarkers and the underlying pathogenesis of diabetic kidney disease.

Authors:  Zeyu Zhang; Maolin Luo; Yongping Lu; Weifeng Feng; Hongwei Wu; Lijing Fan; Baozhang Guan; Yong Dai; Donge Tang; Xiangnan Dong; Chen Yun; Berthold Hocher; Haiping Liu; Qiang Li; Lianghong Yin
Journal:  Int Urol Nephrol       Date:  2022-10-18       Impact factor: 2.266

4.  Adenosine A1 receptor-operated calcium entry in renal afferent arterioles is dependent on postnatal maturation of TRPC3 channels.

Authors:  Hitesh Soni; Dieniffer Peixoto-Neves; Randal K Buddington; Adebowale Adebiyi
Journal:  Am J Physiol Renal Physiol       Date:  2017-08-30

5.  Diabetes downregulates renal adenosine A2A receptors in an experimental model of hypertension.

Authors:  Daniela Patinha; Carla Carvalho; Carla Abreu; Olga M Cunha; Mariana C Mota; Joana Afonso; António Albino-Teixeira; Carmen Diniz; Manuela Morato
Journal:  PLoS One       Date:  2019-05-31       Impact factor: 3.240

6.  SGLT2 inhibitors improve kidney function and morphology by regulating renal metabolic reprogramming in mice with diabetic kidney disease.

Authors:  Yong-Ping Lu; Ze-Yu Zhang; Hong-Wei Wu; Li-Jing Fang; Bo Hu; Chun Tang; Yi-Qing Zhang; Lianghong Yin; Dong-E Tang; Zhi-Hua Zheng; Ting Zhu; Yong Dai
Journal:  J Transl Med       Date:  2022-09-14       Impact factor: 8.440

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.